Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Vaccinia virus/VACV H3L/Ag35 Antibody (B9)

Catalog #:   RVV13802 Specific References (26) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, Neutralization
Accession: P20497, Q0NPX5, Q80DY1
Overview

Catalog No.

RVV13802

Species reactivity

Vaccinia virus

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Envelope protein H3, Ag35, Virion envelope protein p35, H3L, Vaccinia

Concentration

2.89 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P20497, Q0NPX5, Q80DY1

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

PBS, pH 7.4 with 0.2M Arg

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

B9

Data Image
References

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development., PMID:39994775

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART II: Insights into the advancements in vaccines., PMID:39417768

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus., PMID:39321566

Expression of F1L, a vaccinia virus H3L transmembrane protein analogue of orf virus, and its successful purification as a diagnostic antigen., PMID:39136814

Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity., PMID:37300753

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens., PMID:36687315

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization., PMID:35746695

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses., PMID:33675226

Molecular Modelling and Insilico Engineering of PapMV-CP Towards Display and Development of Capripox Viral Like Particles Based on Immunogenic P32 Envelop Protein is the Homologous of the Vaccinia-Viral H3L Gene: An Insilico Approach., PMID:32421016

Phage display antibodies against ectromelia virus that neutralize variola virus: Selection and implementation for p35 neutralizing epitope mapping., PMID:29427674

Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models., PMID:28259752

Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models., PMID:26723250

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies., PMID:23133652

Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs., PMID:22100890

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model., PMID:20587859

Attenuation of vaccinia virus by the expression of human Flt3 ligand., PMID:20504356

An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling., PMID:18480455

Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine., PMID:18234801

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice., PMID:16140750

Heparin binding activity of orf virus F1L protein., PMID:15351483

Identification and characterization of three immunodominant structural proteins of fowlpox virus., PMID:12208962

Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail., PMID:10906204

Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure., PMID:10729126

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo., PMID:10708453

A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene., PMID:10485266

The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein., PMID:9930187

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Vaccinia virus/VACV H3L/Ag35 Antibody (B9) [RVV13802]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only